Risk variables affecting high-grade pap smears at second visit: Effects of screening interval, year, age and low-grade smears

被引:8
作者
Sigurdsson, K [1 ]
Adalsteinsson, S [1 ]
机构
[1] Iceland Canc Soc, Canc Detect Clin, IS-125 Reykjavik, Iceland
关键词
cervical neoplasm; logistic model; mass screening; risk factor; vaginal smear;
D O I
10.1002/ijc.1546
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Our aim was to study the effect, during the period 1979-1996, of the potential risk factors (i) year, age at second visit and first screening interval on the frequency of detection of low- and high-grade smears at the second visit after a normal smears at the first visit; (ii) year, age at second visit and low-grade smears at first visit on the detection of high-grade smears at second visit; (iii) detection of low- and high-grade smears by calendar year at second visit after a normal first visit (period 1981-1996); (iv) proportion of high-grade smears at second visit attributable to low-grade smears at first visit (exposed group); and (v) effect of increasing the screening interval from 2 to 5 years. The results were as follows: (i) low-grade smears increased significantly with years, high-grade smears increased significantly with screening interval and both grades decreased significantly with age; (ii) high-grade smears increased significantly with low-grade smears at first visit and with year but decreased significantly with age; (iii) a significant increase in low-grade smears at second visit with years; (iv) 97% of high-grade smears at second visit were attributable to low-grade smears at first visit; and (v) the risk of high-grade smears was 60% higher when the screening interval was 5 years rather than 2 years after a normal visit at age 20. The strongest risk factors for high-grade cell changes were low-grade smears at first visit [odds ratio 10.2 (ii) and 29.0 (iv)] and first screening interval [odds ratio 1.6 (v)]. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:884 / 888
页数:5
相关论文
共 22 条
[1]  
[Anonymous], 1986, BMJ-BRIT MED J, V293, P659
[2]  
Anttila A, 1999, INT J CANCER, V83, P59, DOI 10.1002/(SICI)1097-0215(19990924)83:1<59::AID-IJC12>3.0.CO
[3]  
2-N
[4]  
BRESLOW NE, 1980, IARC PUBLICATION, V32, P194
[5]  
Cole P., 1978, SCREENING CANCER, V40, P7
[6]  
Day N E, 1986, IARC Sci Publ, P199
[7]  
HAKAMA M, 1988, CANCER SURV, V7, P403
[8]  
*IARC WORK GROUP C, 1986, IARC SCI PUBL, P1
[9]  
KIBUR M, 2000, 18 PAP C PROGR ABSTR, P134
[10]  
KOSS L G, 1987, Applied Pathology, V5, P7